Senti Biosciences, Inc.SNTINASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank74
3Y CAGR-6.2%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-6.2%/yr
Quarterly compound
Percentile
P74
Within normal range
vs 3Y Ago
0.8x
Contraction
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 27.74% |
| Q2 2025 | 6.95% |
| Q1 2025 | -4.04% |
| Q4 2024 | -71.68% |
| Q3 2024 | 5.74% |
| Q2 2024 | 28.57% |
| Q1 2024 | -66.01% |
| Q4 2023 | 54.24% |
| Q3 2023 | -12.46% |
| Q2 2023 | 16.12% |
| Q1 2023 | -81.03% |
| Q4 2022 | 11.15% |
| Q3 2022 | 33.58% |
| Q2 2022 | -51.72% |
| Q1 2022 | 15.97% |
| Q4 2021 | -35.96% |
| Q3 2021 | 36.47% |
| Q2 2021 | 0.00% |
| Q1 2021 | 100.00% |
| Q4 2020 | 0.00% |